Clicky

Crescita Therapeutics Inc.(CRRTF)

Description: Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases, and their symptoms in Canada, Europe, the United States, and internationally. It owns various proprietary drug delivery platforms, including DuraPeel and MMPE that support the development of patented formulations, which facilitate the delivery of active drugs into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; Flexicaine, an anesthetic formulation of lidocaine and tetracaine for the topical treatment of pain conditions; MiCal 1 that is in Phase II clinical trial for the treatment of moderate to severe plaque psoriasis; and MiCal 2, which is in preclinical stage to treat a dermatological skin condition. Its non-prescription skincare products comprise skincare products for aging, acne, rosacea, pigmentation, dehydration, and sensitivity under the Laboratoire Dr Renaud brand; a line of cosmeceutical products for anti-aging medical procedures under the Pro-Derm brand; anti-aging skincare products to consumers of 35 years of age and over under the Premiology brand; a line of products to target and treat various skincare concerns under the Alyria brand; and a range of skincare products for hydration, sun care, atopic dermatitis, baby skin, acne, women's health, and sun damage repair under the ISDIN brand. The company also offers contract manufacturing services. Crescita Therapeutics Inc. has a collaboration agreement with Tetra Natural Health to develop Tetra's dermatology portfolio using the company's transdermal delivery technologies, multiplexed molecular penetration enhancer and DuraPeel. The company was incorporated in 2016 and is headquartered in Laval, Canada.


Keywords: Medicine Pain Health Sciences Pharmacology Skin Care Contract Manufacturing Psoriasis Contract Manufacturing Services Drug Delivery Dermatology Skincare Products Atopic Dermatitis Multiplex Dermatitis Ointments Topical Medication Drug Products Transdermal Plaque Psoriasis A Therapeutic Hydration Natural Health Delivery Technologies Prescription Products Rosacea Anesthetic Cosmeceutical Dehydration Cosmeceutical Products Offers Contract Manufacturing Services Prescription Product Severe Plaque Psoriasis Prescription Drug Products Renaud

Home Page: www.crescitatherapeutics.com

2805 Place Louis-R Renaud
Laval, QC H7V 0A3
Canada
Phone: 905 673 4297


Officers

Name Title
Mr. Serge Verreault B.A., M.B.A. Pres & CEO
Mr. Jose DaRocha C.A., CPA Chief Financial Officer
Mr. Francois Lafortune Exec. VP & GM
Dominic King-Smith VP of Bus. Devel.

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 24.02
Price-to-Book MRQ: 0.6585
Price-to-Sales TTM: 0.4061
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks